1. Home
  2. TECX vs SLRC Comparison

TECX vs SLRC Comparison

Compare TECX & SLRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc.

TECX

Tectonic Therapeutic Inc.

HOLD

Current Price

$30.57

Market Cap

618.9M

Sector

N/A

ML Signal

HOLD

Logo SLR Investment Corp.

SLRC

SLR Investment Corp.

HOLD

Current Price

$12.74

Market Cap

691.2M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
SLRC
Founded
2019
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Finance/Investors Services
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
618.9M
691.2M
IPO Year
2018
2007

Fundamental Metrics

Financial Performance
Metric
TECX
SLRC
Price
$30.57
$12.74
Analyst Decision
Strong Buy
Hold
Analyst Count
5
7
Target Price
$75.20
$15.14
AVG Volume (30 Days)
209.7K
347.0K
Earning Date
05-07-2026
05-05-2026
Dividend Yield
N/A
10.49%
EPS Growth
40.70
N/A
EPS
N/A
0.47
Revenue
N/A
N/A
Revenue This Year
N/A
$1.09
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$27.11
Revenue Growth
N/A
N/A
52 Week Low
$14.39
$12.13
52 Week High
$39.53
$16.75

Technical Indicators

Market Signals
Indicator
TECX
SLRC
Relative Strength Index (RSI) 39.19 49.43
Support Level $27.30 $12.47
Resistance Level $31.39 $13.33
Average True Range (ATR) 2.46 0.19
MACD -0.67 -0.00
Stochastic Oscillator 3.84 47.71

Price Performance

Historical Comparison
TECX
SLRC

About TECX Tectonic Therapeutic Inc.

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. The company focuses on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About SLRC SLR Investment Corp.

SLR Investment Corp is a closed-end externally managed, non-diversified management investment company that has elected to be treated as a business development company. It provides U.S. middle market businesses and intermediaries with bespoke debt financing solutions to fund working capital, acquisition, refinancing and growth capital requirements. The company's investment objective is to generate both current income and capital appreciation through debt and equity investments. The company invests principally in leveraged middle-market companies in the form of senior secured loans, financing leases, and to a lesser extent, unsecured loans and equity securities.

Share on Social Networks: